Skip to main content

Peer Review reports

From: Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients

Original Submission
26 Dec 2015 Submitted Original manuscript
8 Mar 2016 Reviewed Reviewer Report - Christina Wu
6 Aug 2016 Reviewed Reviewer Report - Igor Kiss
7 Sep 2016 Author responded Author comments - Izuma Nakayama
Resubmission - Version 2
7 Sep 2016 Submitted Manuscript version 2
13 Dec 2016 Editorially accepted
9 Jan 2017 Article published 10.1186/s12885-016-2994-6

You can find further information about peer review here.

Back to article page